Federated Hermes’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-93,500
Closed -$1.73M 2282
2017
Q3
$1.73M Hold
93,500
0.01% 985
2017
Q2
$1.55M Sell
93,500
-126,600
-58% -$1.76M ﹤0.01% 1048
2017
Q1
$3.04M Hold
220,100
0.01% 745
2016
Q4
$4.17M Hold
220,100
0.01% 612
2016
Q3
$4.88M Hold
220,100
0.01% 575
2016
Q2
$4.02M Buy
220,100
+117,000
+113% +$2.01M 0.01% 606
2016
Q1
$1.88M Hold
103,100
0.01% 863
2015
Q4
$1.74M Buy
103,100
+45,343
+79% +$770K 0.01% 929
2015
Q3
$1.04M Hold
57,757
﹤0.01% 1083
2015
Q2
$1.49M Hold
57,757
﹤0.01% 1031
2015
Q1
$1.26M Buy
+57,757
New +$1.25M ﹤0.01% 1105

Other funds holding ENTL

Federated Hermes's ENTL Position: Q4 2017 in Review

Federated Hermes sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2017, closing a stake of 93,500 shares — an estimated $1.73M sold.

Federated Hermes first reported a position in ENTL in Q1 2015 and held it in 11 quarters. The position peaked at $4.88M in Q3 2016. 83 funds tracked by Wall St. Rank hold ENTL as of Q4 2017.

  • Federated Hermes reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Federated Hermes sold 93,500 Entellus Medical, Inc. Common Stock shares in Q4 2017, an estimated $1.73M.
  • Federated Hermes first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 11 quarters.
  • Federated Hermes's Entellus Medical, Inc. Common Stock position peaked at $4.88M in Q3 2016.
  • 83 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2017.

Based on Federated Hermes's 13F filing for Q4 2017, filed 14 Feb 2018.